POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDREN

Objective: to evaluate the efficacy of topiramate at a dose of 1–2 mg/kg in 34 patients aged 7–17 with tic hyperkinesis and Tourette syndrome (TS).Materials and methods. We performed clinical evaluation of hyperkinesis severity along with the assessment of somatosensory evoked potentials (SSEP) and...

Full description

Saved in:
Bibliographic Details
Main Authors: V. P. Zykov, E. A. Kashirina, Yu. V. Naugol’nykh
Format: Article
Language:Russian
Published: ABV-press 2017-02-01
Series:Русский журнал детской неврологии
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/181
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339180004409344
author V. P. Zykov
E. A. Kashirina
Yu. V. Naugol’nykh
author_facet V. P. Zykov
E. A. Kashirina
Yu. V. Naugol’nykh
author_sort V. P. Zykov
collection DOAJ
description Objective: to evaluate the efficacy of topiramate at a dose of 1–2 mg/kg in 34 patients aged 7–17 with tic hyperkinesis and Tourette syndrome (TS).Materials and methods. We performed clinical evaluation of hyperkinesis severity along with the assessment of somatosensory evoked potentials (SSEP) and the analysis of surface electromyography (EMG) data prior to treatment initiation and after 6 weeks of therapy. SSEP investigation was carried out in accordance with a standard protocol. Interpeak latencies on the tracks Cp–Fpz (D, S), Cerv6–Fpz (D, S), Erb’i–Erb’c (D, S) were evaluated in order to determine the afferentation between relevant brain structures: N9–N13, N13–N20, N9–N20. N20–P23 potentials reflected primary activity of somatosensory cortex. The investigation of tic hyperkinesis was conducted using surface EMG of facial muscles (m. orbicularis oculi), the muscles of the shoulder girdle (m. supraspinatus), and the muscles of the upper extremities (m. flexor digitorum superficialis) according to the standard protocol. Interference curve was recorded at rest and after hyperkinesis stimulation with the use of provocative tests. High-amplitude (more than 500 mkV) oscillations were considered as burst activity. The severity of clinical manifestations was evaluated using the Yale Global Tic Severity Scale (1989) and the method of tics counting during 20 minutes (V.P. Zykov, 2009). The control group comprised 15 healthy children matched for sex and age.Results. The use of topiramate in patients with chronic motor/vocal tics and TS has significantly decreased the severity of hyperkinesis manifestations, evaluated both by the Yale Global Tic Severity Scale (p < 0,05) and by the method of tics counting during 20 minutes (p < 0,05). It also helped to decrease the prevalence of burst activity in EMG while registering hyperkinesis in different muscle groups. SSEP data showed the normalization of interpeak latency values and the decrease of N20–P23 potentials amplitude, which reflects the decline in the activity of brain somatosensory system, represented by thalamo-cortical structures.Conclusion. Surface EMG and SSEP methods can be used for evaluation of treatment efficacy in cases of tic hyperkinesis and TS.
format Article
id doaj-art-0bce39b5d2a3442cb959dbdc36ac76f8
institution Kabale University
issn 2073-8803
2412-9178
language Russian
publishDate 2017-02-01
publisher ABV-press
record_format Article
series Русский журнал детской неврологии
spelling doaj-art-0bce39b5d2a3442cb959dbdc36ac76f82025-08-20T03:44:11ZrusABV-pressРусский журнал детской неврологии2073-88032412-91782017-02-01114202610.17650/2073-8803-2016-11-4-20-26135POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDRENV. P. Zykov0E. A. Kashirina1Yu. V. Naugol’nykh2Russian Medical Academy of Continuous Professional Education, Ministry of Health of RussiaChildren’s City Polyclinic No 110Children’s City Polyclinic No 110Objective: to evaluate the efficacy of topiramate at a dose of 1–2 mg/kg in 34 patients aged 7–17 with tic hyperkinesis and Tourette syndrome (TS).Materials and methods. We performed clinical evaluation of hyperkinesis severity along with the assessment of somatosensory evoked potentials (SSEP) and the analysis of surface electromyography (EMG) data prior to treatment initiation and after 6 weeks of therapy. SSEP investigation was carried out in accordance with a standard protocol. Interpeak latencies on the tracks Cp–Fpz (D, S), Cerv6–Fpz (D, S), Erb’i–Erb’c (D, S) were evaluated in order to determine the afferentation between relevant brain structures: N9–N13, N13–N20, N9–N20. N20–P23 potentials reflected primary activity of somatosensory cortex. The investigation of tic hyperkinesis was conducted using surface EMG of facial muscles (m. orbicularis oculi), the muscles of the shoulder girdle (m. supraspinatus), and the muscles of the upper extremities (m. flexor digitorum superficialis) according to the standard protocol. Interference curve was recorded at rest and after hyperkinesis stimulation with the use of provocative tests. High-amplitude (more than 500 mkV) oscillations were considered as burst activity. The severity of clinical manifestations was evaluated using the Yale Global Tic Severity Scale (1989) and the method of tics counting during 20 minutes (V.P. Zykov, 2009). The control group comprised 15 healthy children matched for sex and age.Results. The use of topiramate in patients with chronic motor/vocal tics and TS has significantly decreased the severity of hyperkinesis manifestations, evaluated both by the Yale Global Tic Severity Scale (p < 0,05) and by the method of tics counting during 20 minutes (p < 0,05). It also helped to decrease the prevalence of burst activity in EMG while registering hyperkinesis in different muscle groups. SSEP data showed the normalization of interpeak latency values and the decrease of N20–P23 potentials amplitude, which reflects the decline in the activity of brain somatosensory system, represented by thalamo-cortical structures.Conclusion. Surface EMG and SSEP methods can be used for evaluation of treatment efficacy in cases of tic hyperkinesis and TS.https://rjdn.abvpress.ru/jour/article/view/181tic hyperkinesistourette syndromeyale global scalesomatosensory evoked potentialssurface electromyographytopiramate
spellingShingle V. P. Zykov
E. A. Kashirina
Yu. V. Naugol’nykh
POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDREN
Русский журнал детской неврологии
tic hyperkinesis
tourette syndrome
yale global scale
somatosensory evoked potentials
surface electromyography
topiramate
title POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDREN
title_full POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDREN
title_fullStr POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDREN
title_full_unstemmed POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDREN
title_short POSSIBILITIES FOR ANTIEPILEPTIC DRUGS USE IN THE TREATMENT OF TIC HYPERKINESIS AND TOURETTE SYNDROME IN CHILDREN
title_sort possibilities for antiepileptic drugs use in the treatment of tic hyperkinesis and tourette syndrome in children
topic tic hyperkinesis
tourette syndrome
yale global scale
somatosensory evoked potentials
surface electromyography
topiramate
url https://rjdn.abvpress.ru/jour/article/view/181
work_keys_str_mv AT vpzykov possibilitiesforantiepilepticdrugsuseinthetreatmentoftichyperkinesisandtourettesyndromeinchildren
AT eakashirina possibilitiesforantiepilepticdrugsuseinthetreatmentoftichyperkinesisandtourettesyndromeinchildren
AT yuvnaugolnykh possibilitiesforantiepilepticdrugsuseinthetreatmentoftichyperkinesisandtourettesyndromeinchildren